Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Oct, 29 2025
Jan, 17 2026
May, 7 2026
Jan, 3 2026
Jan, 28 2026